Monday, 21 March 2011

Novartis Receives EU Approval For Multiple Sclerosis Drug Gilenya - Update

Source RTT News:

(RTTNews) - Swiss healthcare giant Novartis AG (NVS: News ) Monday said the European Commission approved Gilenya, which would be the first oral multiple sclerosis treatment for use in the EU.   Read more here!